Workflow
Business development
icon
Search documents
Rockwell Medical(RMTI) - 2025 Q1 - Earnings Call Transcript
2025-05-12 13:00
Rockwell Medical (RMTI) Q1 2025 Earnings Call May 12, 2025 08:00 AM ET Speaker0 Good morning, and welcome to Rockwell Medical's First Quarter twenty twenty five Results Conference Call and Webcast. Please note that this event is being recorded. At this time, I would like to turn the conference call over to Heather Hunter, Senior Vice President, Chief Corporate Affairs Officer at Rockwell Medical. Heather, please go ahead. Speaker1 Good morning, and thank you for joining us for this update on Rockwell Medica ...
Prospect Capital Announces Financial Results for Fiscal March 2025 Quarter
Globenewswire· 2025-05-08 20:03
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) today announced financial results for our fiscal quarter ended March 31, 2025. FINANCIAL RESULTS All amounts in $000’s except per share amounts (on weighted average basis for period numbers)Quarter EndedMarch 31, 2025Quarter EndedDecember 31, 2024Quarter EndedMarch 31, 2024 Net Investment Income (“NII”)$83,489$86,431<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; bo ...
Knife River pany(KNF) - 2025 Q1 - Earnings Call Transcript
2025-05-06 16:02
Knife River (KNF) Q1 2025 Earnings Call May 06, 2025 11:00 AM ET Company Participants Nathan Ring - VP & CFOBrian Gray - CEO & PresidentTrey Grooms - Managing DirectorKathryn Thompson - Founding Partner & CEOGarik Shmois - Managing DirectorIan Zaffino - Managing Director Conference Call Participants Brent Thielman - MD & Senior Research AnalystGabe Hajde - Analyst Operator Good morning, ladies and gentlemen, and welcome to the KnifeRiver Corporation First Quarter Results Conference Call. At this time, note ...
Vishay Precision Group(VPG) - 2025 Q1 - Earnings Call Transcript
2025-05-06 13:00
Vishay Precision Group (VPG) Q1 2025 Earnings Call May 06, 2025 09:00 AM ET Speaker0 Hello, everyone, and welcome to the PPG's twenty twenty five First Quarter Earnings Conference Call. My name is Ezra, and I will be your coordinator today. I will now hand you over to your host, Steve Cantor, Senior Director of Investor Relations to begin. Steve, please go ahead. Speaker1 Thank you, Ezra. Good morning, everyone. Welcome to VPG's twenty twenty five first quarter earnings conference call. Our Q1 press release ...
Walmart supports small businesses, American-made products through new 'Grow With US' initiative
Fox Business· 2025-05-03 15:36
Core Insights - Walmart is enhancing support for American-made products through its "Grow With US" initiative, aimed at assisting U.S. small business owners with training, mentorship, and resources for success [1][2] - The initiative includes a four-step program providing financial assistance, e-learning modules, product showcasing opportunities, and mentorship connections [2] - Over two-thirds of Walmart's total product spend in fiscal year 2024 was on items grown, made, or assembled in America, highlighting the importance of small businesses as they account for over 60% of Walmart's U.S. suppliers [5][11] Group 1 - "Grow With US" initiative is part of Walmart's expanding commitment to small business development [2] - The program aligns with similar initiatives in other countries, such as Vriddhi in India and Crece con Walmart in Mexico [4] - Walmart aims to simplify the process for small businesses to collaborate with them, acknowledging the complexities involved [7] Group 2 - Applications for Walmart's annual Open Call event, allowing U.S. businesses to pitch American-made products, will open on June 24, with the event scheduled for October [8] - The announcement follows the opening of Milo's Tea Company's new $200 million manufacturing facility in Spartanburg, South Carolina, supported by Walmart [10] - Walmart emphasizes the role of small businesses as the backbone of communities, citing success stories like that of Milo's Tea [11]
Organon & (OGN) - 2025 Q1 - Earnings Call Transcript
2025-05-01 12:30
Organon (OGN) Q1 2025 Earnings Call May 01, 2025 08:30 AM ET Company Participants Jennifer Halchak - VP, IRKevin Ali - CEOMatthew Walsh - CFOMichael Nedelcovych - Director - Equity ResearchUmer Raffat - Senior Managing DirectorJuan Camilo Ferreira - Executive VP, Head of Research & Development and Chief Medical Officer Conference Call Participants David Amsellem - Sr. Research AnalystEthan Brown - Equity Research AnalystBhavin Patel - Analyst Operator Hello, and welcome to the Organon First Quarter twenty t ...
RECORDATI: 2025-2027 THREE-YEAR PLAN APPROVED FY 2027 TARGETS OF REVENUE BETWEEN € 3,000 AND € 3,200 MILLION; EBITDA(1) BETWEEN € 1,140 AND € 1,225 MILLION; ADJUSTED NET INCOME(2) BETWEEN € 770 AND € 820 MILLION
Globenewswire· 2025-04-28 17:18
RECORDATI: 2025-2027 THREE-YEAR PLAN APPROVED FY 2027 TARGETS OF REVENUE BETWEEN € 3,000 AND € 3,200 MILLION; EBITDA(1) BETWEEN € 1,140 AND € 1,225 MILLION; ADJUSTED NET INCOME(2) BETWEEN € 770 AND € 820 MILLION Milan, 28th April 2025 – The Board of Directors of Recordati S.p.A. has reviewed and approved the plan for the 2025-2027 three-year period. Recordati will continue executing on its strategy focused on driving organic growth of its current product portfolio across both Specialty & Primary Care and Ra ...
Merck(MRK) - 2025 Q1 - Earnings Call Transcript
2025-04-24 18:01
Merck & Co., Inc. (NYSE:MRK) Q1 2025 Earnings Conference Call April 24, 2025 9:00 AM ET Corporate Participants Peter Dannenbaum - Senior Vice President, Investor Relations Rob Davis - Chairman and Chief Executive Officer Caroline Litchfield - Chief Financial Officer Dean Li - President of Merck Research Labs Conference Call Participants Geoff Meacham - Citi Tim Anderson - Bank of America Luisa Hector - Berenberg Vamil Divan - Guggenheim Securities Chris Schott - JPMorgan James Shin - Deutsche Bank Steve Sca ...
Merck(MRK) - 2025 Q1 - Earnings Call Transcript
2025-04-24 20:19
Merck & Co (MRK) Q1 2025 Earnings Call April 24, 2025 04:19 PM ET Company Participants Peter Dannenbaum - Senior VP of Investor RelationsRobert Davis - Chairman & CEOCaroline Litchfield - Executive VP & CFODean Li - EVP & President;, Merck Research LaboratoriesGeoff Meacham - Managing DirectorLuisa Hector - Head of Global Pharma Equity ResearchChris Schott - Managing DirectorJames Shin - Director of Biopharma Equity ResearchAlexandria Hammond - Director, Head of TherapeuticsUmer Raffat - Senior Managing Dir ...
CION Investment: Dividend Cut Likely Despite Strong Fundamentals
Seeking Alpha· 2025-04-23 06:09
Core Viewpoint - The article emphasizes the importance of a hybrid investment strategy that combines high-quality dividend stocks with other asset classes like Business Development Companies, REITs, and Closed End Funds to enhance investment income while achieving total returns comparable to traditional index funds [1]. Group 1: Investment Strategy - A solid base of classic dividend growth stocks can be complemented with other investment vehicles to create a diversified portfolio [1]. - The hybrid system aims to balance growth and income, allowing investors to capture total returns on par with the S&P 500 [1]. Group 2: Investment Focus - The focus is on uncovering high-quality dividend stocks that offer potential for long-term growth and significant income generation [1]. - The strategy includes a mix of different asset types to boost overall investment performance [1].